Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ivabradine in stable angina pectoris (ASSOCIATE)
NCT00202566Phase 3Completed
- Sponsor
- Servier
- Start
- Jun 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of ivabradine in stable angina pectoris, sponsored by Servier. Primary endpoint: Total Exercise Duration at 4 months. Started Jun 2005; status: completed.
02
Drugs
ivabradine
03
Conditions
stable angina pectoris
Beyond the preview
Go deeper on NCT00202566.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00202566.